Ada, G. et al. Vaccines, Vaccination and the Immune Response. Lippincott-Raven Publishers: New York, 1997.

American Academy of Pediatrics, Committee on Infectious Diseases. "Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine." Pediatrics. 1997: 99:300-305

Burke, KL et al. Antigen chimeras of poliovirus as potential new vaccines. 1988, Nature, 332: 81.

Campaign Against Polio. Bulletin of PAHO. 26(4), 1992. p.434 - 437

CDC, Progress Towards Poliomyelitis Eradication - African Region, 1997. MMWR 1998, 47(12):234 - 239

Eibl, M.M. et al. Symposium in Immunology. Springer: New York, 1997.

Global Eradication of Poliomyelitis: Report of the Third Technical Consultation, Geneva. WHO/EPI/GEN. 1998:13

Greenwood, D., et al. Medical Microbiology, 15^th ed. Churchill Livingstone 1997.

Hansen, JL et al. Structure of the RNA-dependent RNA polymerase of poliovirus. 1997, Structure, 5: 1109.

Janeway & Travers: Immunobiology, 3^rd edition. Garland Publishing: 1997.

Kuby, Janis. Immunology. W.H. Freeman and Company: New York, 1997.

Lentz, KN et al. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: Comparison of the structural and biological properties of three poliovirus serotypes. 1997, Structure, 5: 961.

Levine et al. New Generation Vaccines. Marcel Dekkar , Inc: New York, 1997.

Miller, M., et al. "Cost-effectiveness of Incorporating Inactivated Poliovirus Vaccine Into the Routine Childhood Immunization Schedule." 25 Journal of the American Medical Association. 1996; 276: 967-971

Okwo-Bele J, Lobanov A, Biellik R, et al. Overview of Poliomyelitis in the African Region and Current Regional Plan of Action. Journal of Infectious Diseases. 1997: 175 (Suppl 1): S10 - S15

WHA 41/1988/REC/1.The Forty-first World Health Assembly. Handbook of Resolutions and Decisions of the World Health Assembly and the Executive Board. Volume III (1985-1992) WHO: 1993.p.100-101.